Platelet function study in heart surgery
Part of Blood & lymphatic clinical trials.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You are scheduled for planned heart surgery that uses a heart-lung machine.
- You have signed a consent form and understood the procedure.
- Your health status is classified as ASA I, II, III, or IV.
- You have a normal blood clotting test and a normal platelet count before surgery.
- You have stopped taking certain blood thinners long enough before surgery (5 days for clopidogrel or ticagrelor, 7 days for prasugrel).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood cells change during heart surgery and whether these changes affect bleeding or inflammation after the operation. It may help doctors predict and manage complications in people having heart surgery.
This study tests whether using your own donated platelets during heart surgery can help you recover better. Platelets are cells that help your blood clot, and donating them before surgery may reduce the need for donor blood.
This study tests a new blood test that measures how well your blood forms clots. It aims to see if this test can predict bleeding after heart surgery that uses a heart-lung machine, which might help doctors manage bleeding better.
This study watches how well platelets (cells that help blood clot) work in people who have high-risk heart surgery using a heart-lung machine for more than 2 hours. The goal is to learn more about bleeding risks after surgery.
This study looks at how to manage bleeding during and after open heart surgery. If you are having this type of surgery, the research may help improve blood loss control and your recovery.
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
Hear when a new Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.